MTM Investment Management’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$105K Sell
16,275
-600
-4% -$4.14K 0.03% 257
2025
Q4
$133K Sell
16,875
-1,100
-6% -$7.07K 0.04% 238
2025
Q3
$87.9K Hold
17,975
0.03% 282
2025
Q2
$106K Sell
17,975
-600
-3% -$3.17K 0.04% 252
2025
Q1
$109K Hold
18,575
0.04% 208
2024
Q4
$139K Buy
18,575
+1,750
+10% +$13.4K 0.05% 197
2024
Q3
$132K Sell
16,825
-2,050
-11% -$18.5K 0.05% 205
2024
Q2
$158K Sell
18,875
-750
-4% -$6.05K 0.06% 191
2024
Q1
$167K Hold
19,625
0.07% 192
2023
Q4
$167K Sell
19,625
-250
-1% -$2.38K 0.08% 183
2023
Q3
$203K Buy
19,875
+1,500
+8% +$15.6K 0.1% 166
2023
Q2
$239K Hold
18,375
0.12% 161
2023
Q1
$171K Hold
18,375
0.09% 178
2022
Q4
$200K Sell
18,375
-1,150
-6% -$6.27K 0.1% 172
2022
Q3
$79K Hold
19,525
0.04% 198
2022
Q2
$146K Sell
19,525
-500
-2% -$3.95K 0.08% 180
2022
Q1
$180K Sell
20,025
-300
-1% -$2.89K 0.09% 185
2021
Q4
$229K Sell
20,325
-800
-4% -$9.99K 0.11% 171
2021
Q3
$308K Buy
21,125
+3,325
+19% +$50.7K 0.17% 118
2021
Q2
$290K Buy
+17,800
New +$331K 0.15% 123

Other funds holding PROF

MTM Investment Management's PROF Position: Q1 2026 in Review

MTM Investment Management reduced its Profound Medical (PROF) stake by 3.6% in Q1 2026, selling an estimated $4.14K and leaving 16,275 shares worth $105K. The position accounts for 0.03% of the portfolio, ranked #257.

MTM Investment Management first reported a position in PROF in Q2 2021 and has held it in 20 quarters since. The position peaked at $308K in Q3 2021. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • MTM Investment Management held 16,275 shares of Profound Medical worth $105K as of Q1 2026.
  • MTM Investment Management sold 600 Profound Medical shares in Q1 2026, an estimated $4.14K.
  • Profound Medical made up 0.03% of MTM Investment Management's portfolio in Q1 2026, its #257 holding.
  • MTM Investment Management first reported a position in Profound Medical in Q2 2021 and has held it in 20 quarters since.
  • MTM Investment Management's Profound Medical position peaked at $308K in Q3 2021.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on MTM Investment Management's 13F filing for Q1 2026, filed 6 May 2026.